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Parathyroid hormone-mediated aluminum deposition and egress
in the rat. Exogenous PTH significantly enhances tissue alu-
minum concentration in normal rats fed an aluminum-supple-
mented diet. In this study, we examined the effect of P1'H with-
drawal on brain and whole carcass aluminum concentrations.
Four groups of rats were fed an aluminum diet while receiving
injections of PTH for 5 days. On day 5, one group of rats was
sacrificed, and the treatment regimen of the remaining groups al-
tered. PTH, the aluminum diet, or PTH and the aluminum diet
were withdrawn respectively for an additional 5 days. An addi-
tional group of rats was fed the aluminum diet for 10 days. PTH
dramatically increased the concentration of aluminum in both
brain and carcass above that found in tissues of rats given alumi-
num alone. Brain and whole carcass aluminum concentrations
remained elevated in rats continued on P1'H even in the absence
of continued supplemental dietary aluminum. In contrast, fol-
lowing PTH withdrawal, brain and whole carcass aluminum con-
centrations were significantly lower and independent of dietary
aluminum. Thus. PTH may be an important mediator of specific
tissue aluminum burdens.
Deposition d'aluminium ayant l'hormone parathyroIdienne
pour médiateur chez le rat. Le PTH exogène augmente signifi-
cativement Ia concentration tissulaire daluminium chez des rats
normaux noun-is avec une alimentation supplëmentée en alumi-
nium. Dans ce travail nous avons étudié l'effet de Ia suppression
de PTH sur les concentrations d'aluminium du cerveau et de
l'ensemble de corps. Quatre groupes de rats ont recu une alimen-
tation contenant de l'aluminium et des injections de PTH pen-
dant 5 jours. Au 5 jour un groupe de rats a dtd sacriflé et Ic pro-
tocole modiflC pour les groupes restants. Le PTH, l'alimentation
contenant de l'aluminium, ou les deux ont été supprimees pen-
dant une periode de 5 jours. Un cinquième groupe de rats a recu
Ia noumture additionnée d'aluminium pendant lOjours. Le PTH
augmente de facon considerable Ia concentration d'aluminium
aussi bien dans le cerveau que dans l'ensemble de corps: ces
concentrations sont supérieures a celles observées chez les ani-
maux qui ne reçoivent que l'aluminium. Ces concentrations res-
tent Clevées chez les rats qui continuent a recevoir l'hormone
méme apres Ia suppression de l'apport d'aluminium. Aprés Ia
cessation de l'administration de P1'H, au contraire, les concen-
trations d'aluminium dans Ic cerveau et dans l'ensemble de corps
sont significativement supérieures et indépendantes de l'apport
d'aluminium. Ainsi Ic PTH est-elle un mddiateur important de Ia
surcharge tissulaire en aluminium.
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Considerable evidence links increased aluminum
concentration and toxicity in several tissues, includ-
ing red blood cell [I], heart [I], kidney [2], bone [3],
and, in particular, brain [4]. The potential neuro-
toxicity of aluminum is supported by animal experi-
ments that demonstrate that aluminum applied di-
rectly to brain induces a variety of neurologic [4]
and behavioral abnormalities [5]. In patients dying
of the dialysis encephalopathy syndrome, Aifrey,
LeGendre, and Kaehny [6] have reported in-
creased aluminum concentrations in bone, muscle,
and particularly brain gray matter. The association
between dialysis encephalopathy and aluminum has
been supported in several dialysis centers through-
out Europe [7, 8] and North America [9].
Aluminum may enter the body through the dialy-
sate or via the gastrointestinal tract. There is con-
vincing evidence that both aluminum contamination
of dialysate [7-10] and orally ingested aluminum in
the form of phosphate-binding antacid gels contrib-
ute to increased specific tissue aluminum burdens
[11—13]. Nevertheless, neither oral aluminum ex-
posure nor contaminated dialysate fully explain the
pathogenesis of this disease, suggesting that either
aluminum is not the toxic substance or that other
factors may be involved.
PTH could be an additional factor affecting body
aluminum burdens. Most dialysis patients have high
endogenous PTH concentrations [14], which have
been associated with multiple neurologic abnormal-
ities [15]. Recently, we have demonstrated that
PTH may augment the absorption of aluminum
from the gastrointestinal tract and specifically alter
tissue distribution of aluminum [16, 17], perhaps
contributing to PTH-mediated neurologic abnor-
malities.
Because existing evidence links elevated brain
aluminum concentrations and the dialysis encepha-
lopathy syndrome, the identification of factors that
Aluminum deposition and egress jn the rat 41
influence deposition or egress of aluminum in brain
may clarify the pathogenesis of this disease and pro-
vide a physiologic approach to therapy. This study
in normal rats was initiated to evaluate the effect of
PTH withdrawal on brain and whole carcass alumi-
num burdens.
Methods
Four groups of male Sprague-Dawley rats (250 to
300 g) were treated for 5 days with PTH extract
(TCA-Inolex Pharmaceuticals, Glenwood, Illinois)
injected s.c. every 12 hours and maintained on a
ground diet (Wayne Lab Blox, Chicago, Illinois)
supplemented with 0.2% aluminum, by weight, as
aluminum chloride (Fisher, Fairlawn, New Jersey).
PTH dosage was 5.5 lU/day in vehicle of 84. 1% wa-
ter, 15% gelatin, 0.1% phenol, and 0.8% glycerin.
Aluminum concentration of the PTH extract and
the vehicle was below the detection limit (20 pg/li-
ter) of the method. On day 5, group A was sacri-
ficed, and the treatment regimen of the remaining
groups was altered. Group B continued to receive
PTH, but was placed on a standard ground diet
without supplemental aluminum. Group C was con-
tinued on the aluminum-supplemented diet, but was
not given PTH. Group D received neither PTH nor
the aluminum-supplemented diet. The rats re-
mained on these treatments for an additional 5 days
and were then sacrificed. A final group of animals
(group E) was fed the aluminum supplemented diet
for 10 days. Animals were sacrificed by cervical dis-
location (Table 1) or exsanguination via the hepatic
sinus (Table 2). Where appropriate, the entire gas-
trointestinal tract was carefully ligated, removed,
and discarded to prevent contamination from alumi-
num contained in the gastrointestinal tract. Whole
brains were then removed, and the remaining car-
cass was autoclaved at 120° C for 20 mm and ho-
mogenized in a Waring blender.
Tissue preparation and aluminum determination
was similar to the method described by Krishnan,
Gillespie, and Crapper [18]. To minimize aluminum
contamination, we washed all glassware with deter-
gent (Alconox®, New York, New York), soaked it
in 0.5% nitric acid (Ultrex-Baker, Phillipsburgh,
New Jersey), and thoroughly rinsed it with deion-
ized distilled water. Wet tissue digestions were per-
formed in duplicate on whole brains and aliquots of
homogenized carcass in tared 250-ml flasks with 4.0
ml of concentrated nitric acid and 1.0 ml of concen-
trated perchloric acid (Fisher, Fairlawn, New Jer-
sey) per gram of tissue. The flasks were left stand-
ing undisturbed for 1 hour to avoid frothing and
were placed on a hot plate with temperatures main-
tained below 120° C. Samples were evaporated to
dryness (about 1 hour) and taken up with deionized
distilled water. Standards were prepared from
aluminum chloride with 500 jtg/liter sodium (as so-
dium chloride), added to suppress ionization [18].
Aluminum analyses were performed on both a Per-
kin Elmer model 460 and a Varian Techtron model
375 atomic absorption spectrophotometer at a
wavelength of 309.3 nm with a nitrous-oxide-acetyl-
ene flame. Recovery studies with A1C136H2O
agreed within 5%. Representative samples were
also analyzed by flameless atomic absorption spec-
trophotometry with an EDTA extraction, as pre-
viously described [19, 20] in both our laboratory
(Table 2) and an independent laboratory. Aluminum
determinations were found to be similar by several
methods in the two different laboratories. Total
body aluminum burdens were calculated from the rat
carcass aluminum concentration and the body
weight.
Standard automated techniques were used to de-
termine the serum urea nitrogen concentration
(BUN analyzer; Beckman) based on the con-
ductivity rate methodology, the serum creatinine
concentration (autoanalyzer; Technicon) after a
modification of the Jaffe method, and the total
serum calcium concentration by flame atomic ab-
sorption spectrophotometry (Varian Techtron).
Statistical analysis was by analysis of variance
and Tukey's test of means [21] with P < 0.05 con-
sidered the criterion of significance.
Results
Brain and whole carcass aluminum concentra-
tions and total body aluminum burdens at the time
of sacrifice are shown in Table 1. Animals treated
with PTH and oral aluminum for 5 days (group A)
exhibited significantly greater brain (13-fold) and
whole carcass (15-fold) aluminum concentrations
than the animals treated with aluminum alone for 10
days (group E). There was no significant difference
in weight among the five groups of animals, in-
dicating that comparable amounts of the various
diets were consumed. Brain and whole carcass con-
centrations seen in group A should reflect aluminum
concentrations of animals in groups B, C, and D on
day 5. Brain, whole carcass, and total body alumi-
num burdens remained elevated in rats continued
on P1'H despite the replacement of the 0.2% alumi-
num-supplemented diet with a standard diet (group
B). In contrast, withdrawal of PTH (group C) or
both PTH and the aluminum diet (group D) after
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Table 1. Brain and whole carcass aluminum concentrations and total body aluminum burdensa
Values are means I SD (N = 4).
Aluminum determinations were by flameless atomic absorption
day 5 resulted in significantly lower brain and whole
carcass aluminum concentrations. Animals contin-
ued on the aluminum-supplemented diet (group C)
did not demonstrate brain or whole carcass alumi-
num concentrations or total body aluminum bur-
dens significantly different from animals continued
on the Lab Blox diet (group D). Furthermore, fol-
lowing the withdrawal of PTH, the percent decrease
of whole carcass aluminum concentration was ap-
proximately 3.5 times greater than the percent de-
crease of brain aluminum.
In identically treated animals (Table 2), no signifi-
cant change in serum urea nitrogen was noted in
any group. Serum creatinine concentration of all an-
imals were below 0.7 mg!dl. Total serum calcium
concentration increased in the animals receiving
PTH and fell following P1'H withdrawal. Brain
aluminum concentrations were similar to animals
depicted in Table 1.
Discussion
Aluminum concentration in brain and carcass of
rats treated with aluminum and PTH for 5 days was
significantly higher than those treated for 10 days
with an aluminum-supplemented diet alone. The ad-
dition of PTH resulted in an increment in brain and
whole carcass aluminum concentration of approxi-
mately 13- and 15-fold, respectively. PTH also in-
creased mean total body aluminum burdens by 2.94
spectrophotometry.
mg (10-fold). Withdrawal of PTH resulted in a de-
crease of aluminum concentrations of both brain
and whole carcass, thus demonstrating a rapid
egress of aluminum from these tissues. The 2.6 mg
decrement in whole body aluminum burdens sug-
gests a net negative aluminum balance. In addition,
the fall in brain aluminum concentration was less
marked than the fall in whole carcass aluminum
concentration, demonstrating differing net alumi-
num egress from different tissue pools.
Brain and total body concentrations of aluminum
in rats continued on PTH after day 5 (group B) were
significantly higher than those seen following PTH
withdrawal. This effect was independent of dietary
aluminum content, suggesting a role for PTH in
maintaining increased specific tissue aluminum bur-
dens even in the absence of continued aluminum ex-
posure. This study confirms our previous finding
[16] that PTH increased brain aluminum burdens
and, in addition, demonstrates that PTH withdrawal
results in a rapid decrease of brain and whole body
aluminum burdens. These data also suggest that
PTH may have a greater effect than dietary alumi-
num on determining specific tissue aluminum bur-
dens.
High brain aluminum concentrations have been
implicated in the etiology of the dialysis encepha-
lopathy syndrome [6]. Factors responsible for
aluminum deposition in brain, however, remain un-
Treatment days Aluminum concentration
.sg Aug wet wt
Group Total body(N = 4) 1 to 5 6 to 10 Brain Whole carcass aluminum burden, mg
A Al + PTH — 10.98 1.28 8.68 3.64 3.288 1.480
B Al + PTH PTH 11.36 1.39 8.38 3.64 3.263 1.3 14
C Al + PTH Al 4.00 0•44b 0.94 062b 0.378 0.259k'
D Al + P1'H Normal diet 4.70 0.9P' 1.42 0.56k' 0.577 0210b
E Al Al 0.82 0.l8 0.58 0.57" 0.351 0.222"
a Aluminum determinations by both flame and flameless atomic absorption spectrophotometry. Values are means SD.
bSignificantly different from groups A and B.
Significantly different from groups A, B, C, and D.
Table 2. Serum urea nitrogen, calcium, and brain aluminum concentrationsa
BUN, mgldl Calcium, rng/dl Brain aluminum", pg Aug
Group Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 Day 5 Day 10
A 20.6 3.0 20.7 2.8 — 11.8 1.2 15.0 1.8 — 13.85 2.23 —
B 20.0 2.9 19.4 3.4 24.9 2.4 10.6 1.1 15.8 1.7 16.7 2.2 — 10.44 0.89
C 24.8 5.5 21.9 3.4 21.5 3.5 11.4 1.0 15.9 1.6 10.1 1.1 — 6.10 1.22
D 19.3 1.5 23.5 2.1 23.7 3.2 11.0 1.2 15.2 1.5 11.7 1.1 — 4.55 1.35
E 22.2 3.6 20.0 3.2 22.6 6.3 10.6 0.9 10.2 0.3 10.0 0.8 — 0.71 0.19
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clear. This study, and previous studies [16, 17],
strongly suggests that PTH influences brain alumi-
num burdens in normal rats. These data do not
clearly define the specific mode by which PTH in-
fluences aluminum metabolism. The markedly en-
hanced total body aluminum burdens seen in ani-
mals treated with PTH and dietary aluminum
strongly suggest, however, enhanced gastrointesti-
nal absorption of aluminum. These data could also
be explained by decreased aluminum excretion re-
sulting from impaired renal function induced by
hypercalcemia from PTH. These manipulations of
PTH and diet, however, did not alter serum urea
nitrogen or creatinine concentration, although an-
ticipated changes in serum calcium concentrations
were seen. Thus, the failure of these treatments to
alter serum urea nitrogen and creatinine argues
against this possibility.
Furthermore, this study indicates that PTH may
also affect the bidirectional transport of aluminum
in specific tissues. Attempts to reduce aluminum
burdens in affected patients have thus far been un-
successful. Dialysis or the return of renal function
by transplantation appears to have little effect on
reducing aluminum burdens [8, 22]. These observa-
tions are consistent with our data indicating that
aluminum burdens are maintained in the presence
of normal renal function if FF11 is elevated. It is of
interest that two patients reported to have had a re-
mission of this syndrome had undergone a para-
thyroidectomy [23, 24]. Therefore, the observation
that PTH withdrawal from normal animals results in
a rapid egress of aluminum may have therapeutic
significance.
There are many factors in uremia that may play a
role in aluminum metabolism. It appears that alumi-
num contamination of dialysate is a major source of
aluminum in dialysis patients. Oral aluminum may
also enhance specific tissue burdens of aluminum.
In addition, PTH may be an important mediator of
specific tissue aluminum burdens. The enhanced
brain and whole body aluminum burdens after PTH
treatment and the rapid fall following PTH with-
drawal support an important role for PTH in alumi-
num metabolism.
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